Get the Stockscreener App
10.08
1.10%
0.11
After Hours:
10.31
0.23
+2.28%
Wave Life Sciences Ltd stock is traded at $10.08, with a volume of 1.44M.
It is up +1.10% in the last 24 hours and up +20.00% over the past month.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
See More
Previous Close:
$9.97
Open:
$9.87
24h Volume:
1.44M
Relative Volume:
1.01
Market Cap:
$1.60B
Revenue:
$93.95M
Net Income/Loss:
$-129.87M
P/E Ratio:
-11.20
EPS:
-0.9
Net Cash Flow:
$-202.88M
1W Performance:
+6.67%
1M Performance:
+20.00%
6M Performance:
-4.55%
1Y Performance:
+78.41%
1-Day Range:
$9.87
$10.41
1-Week Range:
$9.38
$10.57
52-Week Range:
$5.04
$16.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Name
Wave Life Sciences Ltd
Sector
Industry
Phone
617-949-2900
Address
7 STRAITS VIEW, SINGAPORE
Compare WVE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
10.08 | 1.58B | 93.95M | -129.87M | -202.88M | -0.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.72B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.50 | 60.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 58.15B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 41.45B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-04-25 | Initiated | Canaccord Genuity | Buy |
| Jul-28-25 | Initiated | Oppenheimer | Outperform |
| Jul-16-25 | Initiated | Citigroup | Buy |
| Jun-11-25 | Resumed | Raymond James | Outperform |
| Apr-29-25 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-08-25 | Initiated | Wedbush | Outperform |
| Feb-25-25 | Initiated | Jefferies | Buy |
| Oct-16-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-27-24 | Resumed | JP Morgan | Overweight |
| Sep-19-24 | Initiated | B. Riley Securities | Buy |
| Sep-09-24 | Initiated | JP Morgan | Overweight |
| May-15-24 | Initiated | Wells Fargo | Overweight |
| Dec-19-23 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jul-05-23 | Initiated | Raymond James | Outperform |
| May-24-23 | Downgrade | Jefferies | Buy → Hold |
| Dec-15-20 | Resumed | H.C. Wainwright | Buy |
| Oct-23-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-31-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Nov-01-19 | Initiated | Guggenheim | Buy |
| Jul-15-19 | Initiated | Cowen | Market Perform |
| Apr-17-19 | Reiterated | H.C. Wainwright | Buy |
| Aug-07-18 | Initiated | Stifel | Buy |
| Jul-23-18 | Initiated | H.C. Wainwright | Buy |
| Mar-19-18 | Reiterated | Mizuho | Buy |
| Feb-15-17 | Initiated | H.C. Wainwright | Buy |
| Nov-10-16 | Resumed | Leerink Partners | Outperform |
| Dec-07-15 | Initiated | JMP Securities | Mkt Outperform |
| Dec-07-15 | Initiated | Jefferies | Buy |
| Dec-07-15 | Initiated | Leerink Partners | Outperform |
| Dec-07-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Wave Life Sciences Ltd Stock (WVE) Latest News
How institutional ownership impacts Wave Life Sciences Ltd. stockTake Profit & Intraday High Probability Setup Alerts - Newser
Detecting price anomalies in Wave Life Sciences Ltd. with AI2025 Volatility Report & Risk Managed Investment Signals - Newser
Should you hold or exit Wave Life Sciences Ltd. nowDay Trade & Daily Profit Focused Screening - Newser
What MACD and RSI say about Wave Life Sciences Ltd.2025 Winners & Losers & Detailed Earnings Play Strategies - Newser
What momentum shifts mean for Wave Life Sciences Ltd.July 2025 Intraday Action & Low Drawdown Investment Strategies - Newser
Risk adjusted return profile for Wave Life Sciences Ltd. analyzedMarket Movement Recap & Safe Entry Zone Identification - Newser
Wave Life Sciences Executives Conduct Significant Share Transactions - TradingView
Wave Life Sciences CEO Paul Bolno Sells 217351 Shares at $10.1 on 2025-08-22. - AInvest
Will earnings trigger a reversal in Wave Life Sciences Ltd.Treasury Yields & Real-Time Stock Entry Alerts - Newser
How to build a dashboard for Wave Life Sciences Ltd. stockGap Up & Verified Stock Trade Ideas - Newser
Will breakout in Wave Life Sciences Ltd. lead to full recoveryCEO Change & Daily Stock Trend Reports - Newser
Using Python tools to backtest Wave Life Sciences Ltd. strategies2025 Institutional Moves & Fast Exit and Entry Strategy Plans - Newser
What makes Wave Life Sciences Ltd. stock price move sharply2025 Sector Review & Safe Capital Preservation Plans - Newser
Can machine learning forecast Wave Life Sciences Ltd. recoveryQuarterly Profit Review & Real-Time Buy Signal Notifications - Newser
How to integrate Wave Life Sciences Ltd. into portfolio analysis toolsJuly 2025 Big Picture & Low Risk High Win Rate Stock Picks - Newser
Chart based analysis of Wave Life Sciences Ltd. trendsWeekly Investment Summary & Low Risk Entry Point Guides - Newser
Wave Life Sciences Ltd. stock daily chart insightsTrade Risk Assessment & Daily Volume Surge Signals - Newser
Wave Life Sciences is a new Buy at Canaccord Genuity on near-term catalysts - MSN
When is the best time to exit Wave Life Sciences Ltd.Weekly Trading Summary & Free Expert Approved Momentum Trade Ideas - Newser
Will Wave Life Sciences Ltd. continue its uptrend2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - Newser
Custom watchlist performance reports with Wave Life Sciences Ltd.Quarterly Earnings Summary & AI Powered Buy and Sell Recommendations - Newser
10 Best Biotech Stocks to Buy Under $10 - Insider Monkey
Top chart patterns to watch in Wave Life Sciences Ltd.Quarterly Profit Report & Risk Managed Investment Strategies - Newser
Relative strength of Wave Life Sciences Ltd. in sector analysis2025 Risk Factors & Consistent Growth Equity Picks - Newser
Is Wave Life Sciences Ltd. forming a bottoming base2025 Market Outlook & Weekly High Momentum Picks - Newser
Is Wave Life Sciences Ltd. reversing from oversold territoryTreasury Yields & Community Verified Swing Trade Signals - Newser
Wave Life Sciences Ltd. shares rise 5.64% intraday as biotech sector growth and innovation fuel optimism. - AInvest
Block Trades: Will Wave Life Sciences Ltd. benefit from sector rotation2025 Market Trends & Weekly Top Gainers Alerts - sundaytimes.kr
Pattern Scan Adds Wave Life Sciences Ltd. to WatchlistFed Meeting & Verified Trade Idea Suggestions - beatles.ru
Commit To Purchase Wave Life Sciences At $7.50, Earn 26.5% Annualized Using Options - Nasdaq
Earnings call transcript: Wave Life Sciences Q2 2025 shows revenue miss - Investing.com
Wave Life Sciences gains as JPMorgan suspends rating (update) - MSN
Tan Aik Na sells Wave Life Sciences (WVE) shares for $194k - Investing.com Nigeria
Applying big data sentiment scoring on Wave Life Sciences Ltd.Trade Risk Report & Community Consensus Stock Picks - Newser
What does recent volatility data suggest for Wave Life Sciences Ltd.2025 Investor Takeaways & Expert Approved Trade Ideas - Newser
Wave Life Sciences gains as JPMorgan suspends rating (update) (WVE:NASDAQ) - Seeking Alpha
Wave Life Sciences Ltd. shares rise 2.69% intraday after Ocean Power Technologies, Inc. highlights marine energy innovations. - AInvest
Analyzing Wave Life Sciences Ltd. with risk reward ratio chartsQuarterly Profit Report & Weekly Market Pulse Updates - Newser
Wave Life Sciences Ltd. Recovery Linked to Earnings SurpriseJuly 2025 Highlights & High Accuracy Trade Signal Alerts - newsyoung.net
Wave Life Sciences director Henry sells $85k in shares By Investing.com - Investing.com Nigeria
Wave Life Sciences director Henry sells $85k in shares - Investing.com
Wave Life Sciences Ltd Stock (WVE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Wave Life Sciences Ltd Stock (WVE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BOLNO PAUL | President and CEO |
Aug 22 '25 |
Sale |
10.10 |
217,351 |
2,194,810 |
121,000 |
0.98%
8.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):